NCT02505516

Brief Summary

patients om metformin from diabetic clinic were checked for bladder cancer

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for early_phase_1

Timeline
Completed

Started Jun 2013

Shorter than P25 for early_phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2013

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2014

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2014

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

July 20, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 22, 2015

Completed
Last Updated

July 22, 2015

Status Verified

July 1, 2015

Enrollment Period

7 months

First QC Date

July 20, 2015

Last Update Submit

July 21, 2015

Conditions

Bladder CancerDiabetes

Keywords

pathology

Outcome Measures

Primary Outcomes (1)

  • Number of diabetic patients on metformin therapy

    6 months

Study Arms (2)

metformin

PLACEBO COMPARATOR

metformin 500mg

Other: metformin

not on metformin

NO INTERVENTION

Interventions

metforminOTHER
Also known as: glucophage
metformin

Eligibility Criteria

Age25 Years - 86 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • people attending diabetic clinic

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universty of Capecoast

Cape Coast, Ghana

Location

MeSH Terms

Conditions

Urinary Bladder NeoplasmsDiabetes Mellitus

Interventions

Metformin

Condition Hierarchy (Ancestors)

Urologic NeoplasmsUrogenital NeoplasmsNeoplasms by SiteNeoplasmsFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrinary Bladder DiseasesUrologic DiseasesMale Urogenital DiseasesGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

BiguanidesGuanidinesAmidinesOrganic Chemicals

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
miss

Study Record Dates

First Submitted

July 20, 2015

First Posted

July 22, 2015

Study Start

June 1, 2013

Primary Completion

January 1, 2014

Study Completion

February 1, 2014

Last Updated

July 22, 2015

Record last verified: 2015-07

Locations

GH(1)